Investor Alert

Pfizer Inc.



After Hours

 --Quotes are delayed by 20 min

Oct 23, 2020, 7:59 p.m.





-0.06 -0.16%


Volume 3.76m

Quotes are delayed by 20 min


Previous close

$ 37.43

$ 38.18


+0.75 +2.00%

Day low

Day high




52 week low

52 week high




Annual Financials for Pfizer Inc.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 48.85B52.82B52.55B53.65B51.75B
Cost of Goods Sold (COGS) incl. D&A 13.16B15.95B15.78B16.01B14.74B
COGS excluding D&A 8B10.2B9.51B9.62B8.73B
Depreciation & Amortization Expense 5.16B5.76B6.27B6.38B6.01B
Depreciation 1.43B1.7B1.51B1.49B1.4B
Amortization of Intangibles 3.73B4.06B4.76B4.89B4.61B
Gross Income 35.69B36.87B36.77B37.64B37.01B
20152016201720182019 5-year trend
SG&A Expense 22.4B22.6B22.38B22.35B22.89B
Research & Development 7.67B7.84B7.65B7.97B8.62B
Other SG&A 14.73B14.76B14.73B14.38B14.27B
Other Operating Expense -----
Unusual Expense 3.97B6.65B2.24B3.62B4.53B
EBIT after Unusual Expense (3.97B)7.62B(2.24B)11.67B9.59B
Non Operating Income/Expense 321M1.45B1.04B1.2B9.42B
Non-Operating Interest Income 471M470M391M333M226M
Equity in Affiliates (Pretax) 45M---17M
Interest Expense 1.2B1.19B1.27B1.32B1.57B
Gross Interest Expense 1.23B1.25B1.34B1.39B1.66B
Interest Capitalized 32M61M72M73M88M
Pretax Income 8.97B8.35B12.31B11.89B17.68B
Income Tax 1.99B1.12B(9.05B)706M1.38B
Income Tax - Current Domestic 59M290M14.45B(2.36B)(1.94B)
Income Tax - Current Foreign 1.95B1.53B2.71B2.83B2.9B
Income Tax - Deferred Domestic 264M(525M)(26.16B)792M1.35B
Income Tax - Deferred Foreign (284M)(175M)(42M)(558M)(919M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 6.98B7.23B21.35B11.18B16.3B
Minority Interest Expense 26M31M47M36M29M
Net Income 6.95B7.2B21.31B11.14B16.27B
Extraordinaries & Discontinued Operations 11M17M2M10M4M
Extra Items & Gain/Loss Sale Of Assets (6M)-3M--
Cumulative Effect - Accounting Chg -----
Discontinued Operations 17M17M(1M)10M4M
Net Income After Extraordinaries 6.96B7.22B21.31B11.15B16.27B
Preferred Dividends 1M1M1M1M1M
Net Income Available to Common 6.97B7.21B21.3B11.15B16.27B
EPS (Basic)
Basic Shares Outstanding 6.18B6.09B5.97B5.87B5.57B
EPS (Diluted)
Diluted Shares Outstanding 6.26B6.16B6.06B5.98B5.68B
EBITDA 18.45B20.03B20.66B21.67B20.13B
Link to MarketWatch's Slice.